Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Tuberculosis

Free Subscription Articles published in Lancet Retrieve available abstracts of 68 articles: HTML format Text format

Single Articles

May 2018
1. COUSINS S
   Managing MDR tuberculosis in Nepal.
   Lancet. 2018;391:1760-1761.
   PubMed     Text format    
   
   
   March 2018
2. SHARMA D
   Commitments to an end to tuberculosis renewed in India.
   Lancet. 2018;391:1138.
   PubMed     Text format    
   
   
   
3. GOOSBY E, Jamison D, Swaminathan S, Reid M, et al
   The Lancet Commission on tuberculosis: building a tuberculosis-free world.
   Lancet. 2018;391:1132-1133.
   PubMed     Text format    
   
   
   
4. WINGFIELD T, Tovar MA, Datta S, Saunders MJ, et al
   Addressing social determinants to end tuberculosis.
   Lancet. 2018;391:1129-1132.
   PubMed     Text format    
   
   
   
5. DAVIES R
   Leo Martinez: striving to end childhood tuberculosis.
   Lancet. 2018 Mar 21. pii: S0140-6736(18)30680.
   PubMed     Text format    
   
   
   January 2018
6. THE LANCET
   Tuberculosis: criteria for global leadership?
   Lancet. 2018;391:2.
   PubMed     Text format    
   
   
   September 2017
7. POKROVSKY V
   Tuberculosis and HIV/AIDS: the alien and the predator.
   Lancet. 2017;390:1618-1619.
   PubMed     Text format    
   
   
   
8. COX H, Reuter A, Furin J, Seddon J, et al
   Prevention of hearing loss in patients with multidrug-resistant tuberculosis.
   Lancet. 2017;390:934.
   PubMed     Text format    
   
   
   June 2017
9. VENKATESH P
   Tuberculosis in India: health policy alone is not enough.
   Lancet. 2017;389:2471.
   PubMed     Text format    
   
   
   
10. PAI M, Jha P
    Tuberculosis in India: health policy alone is not enough - Authors' reply.
    Lancet. 2017;389:2471-2472.
    PubMed     Text format    
    
    
    March 2017
11. SHARMA DC
    New plan to end tuberculosis in south and southeast Asia.
    Lancet. 2017;389:1183.
    PubMed     Text format    
    
    
    
12. ADAM BU, Cosford P, Anderson SR, Abubakar I, et al
    Sustaining tuberculosis decline in the UK.
    Lancet. 2017;389:1176-1177.
    PubMed     Text format    
    
    
    
13. PAI M, Correa N, Mistry N, Jha P, et al
    Reducing global tuberculosis deaths-time for India to step up.
    Lancet. 2017;389:1174-1176.
    PubMed     Text format    
    
    
    February 2017
14. SHARMA DC
    India plans to expand access to new tuberculosis drug.
    Lancet. 2017;389:685.
    PubMed     Text format    
    
    
    
15. COUSINS S
    Myanmar grapples with its high tuberculosis burden.
    Lancet. 2017;389:491-492.
    PubMed     Text format    
    
    
    January 2017
16. CLINTON C, Sridhar D
    Who pays for cooperation in global health? A comparative analysis of WHO, the World Bank, the Global Fund to Fight HIV/AIDS, Tuberculosis and Malaria, and Gavi, the Vaccine Alliance.
    Lancet. 2017 Jan 27. pii: S0140-6736(16)32402.
    PubMed     Text format     Abstract available
    
    
    November 2016
17. CARRUTH L, Roess AA, Mekonnen YT, Melaku SK, et al
    Zoonotic tuberculosis in Africa: challenges and ways forward.
    Lancet. 2016;388:2460-2461.
    PubMed     Text format    
    
    
    
18. BERRY C, Achar J, du Cros P
    WHO recommendations for multidrug-resistant tuberculosis.
    Lancet. 2016;388:2234.
    PubMed     Text format    
    
    
    
19. SOTGIU G, Tiberi S, D'Ambrosio L, Centis R, et al
    WHO recommendations for multidrug-resistant tuberculosis - Authors' reply.
    Lancet. 2016;388:2234-2235.
    PubMed     Text format    
    
    
    
20. ZAK D, Scriba TJ, Hatherill M, Penn-Nicholson A, et al
    Predicting tuberculosis risk - Authors' reply.
    Lancet. 2016;388:2233-2234.
    PubMed     Text format    
    
    
    
21. KIK SV, Cobelens F, Moore D
    Predicting tuberculosis risk.
    Lancet. 2016;388:2233.
    PubMed     Text format    
    
    
    October 2016
22. NADDA JP, Singh PK
    New evidence of the tuberculosis burden in Asia demands national action.
    Lancet. 2016 Oct 14. pii: S0140-6736(16)31853.
    PubMed     Text format    
    
    
    
23. ALDRIDGE RW, Zenner D, White PJ, Williamson EJ, et al
    Tuberculosis in migrants moving from high-incidence to low-incidence countries: a population-based cohort study of 519 955 migrants screened before entry to England, Wales, and Northern Ireland.
    Lancet. 2016 Oct 10. pii: S0140-6736(16)31008.
    PubMed     Text format     Abstract available
    
    
    
24. REINL J
    UN declaration on antimicrobial resistance lacks targets.
    Lancet. 2016;388:1365.
    PubMed     Text format    
    
    
    
25. CHEN S, Zhang H, Qu Y, Wu Y, et al
    Occupational challenges of physicians involved in tuberculosis control in China: a qualitative study.
    Lancet. 2016;388 Suppl 1:S88.
    PubMed     Text format     Abstract available
    
    
    
26. GAO L, Bai L, Liu J, Lu W, et al
    Identification of populations at high risk of tuberculosis infection in rural China: a population-based, multicentre, prospective study.
    Lancet. 2016;388 Suppl 1:S16.
    PubMed     Text format     Abstract available
    
    
    July 2016
27. FEDER HM JR, Rigos L, Teti K
    Pott's disease in a Connecticut toddler.
    Lancet. 2016;388:504.
    PubMed     Text format    
    
    
    
28. KAMARULZAMAN A, Reid SE, Schwitters A, Wiessing L, et al
    Prevention of transmission of HIV, hepatitis B virus, hepatitis C virus, and tuberculosis in prisoners.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30769.
    PubMed     Text format     Abstract available
    
    
    
29. ALTICE FL, Azbel L, Stone J, Brooks-Pollock E, et al
    The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30856.
    PubMed     Text format     Abstract available
    
    
    
30. DOLAN K, Wirtz AL, Moazen B, Ndeffo-Mbah M, et al
    Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30466.
    PubMed     Text format     Abstract available
    
    
    
31. RICH JD, Beckwith CG, Macmadu A, Marshall BD, et al
    Clinical care of incarcerated people with HIV, viral hepatitis, or tuberculosis.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30379.
    PubMed     Text format     Abstract available
    
    
    
32. TELISINGHE L, Charalambous S, Topp SM, Herce ME, et al
    HIV and tuberculosis in prisons in sub-Saharan Africa.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30578.
    PubMed     Text format     Abstract available
    
    
    
33. RUBENSTEIN LS, Amon JJ, McLemore M, Eba P, et al
    HIV, prisoners, and human rights.
    Lancet. 2016 Jul 14. pii: S0140-6736(16)30663.
    PubMed     Text format     Abstract available
    
    
    June 2016
34. DONALD PR, Van Toorn R
    Use of corticosteroids in tuberculous meningitis.
    Lancet. 2016;387:2585-7.
    PubMed     Text format    
    
    
    
35. SOTGIU G, Tiberi S, D'Ambrosio L, Centis R, et al
    WHO recommendations on shorter treatment of multidrug-resistant tuberculosis.
    Lancet. 2016;387:2486-7.
    PubMed     Text format    
    
    
    March 2016
36. LEVIN M, Kaforou M
    Predicting active tuberculosis progression by RNA analysis.
    Lancet. 2016 Mar 23. pii: S0140-6736(16)00165.
    PubMed     Text format    
    
    
    
37. ZAK DE, Penn-Nicholson A, Scriba TJ, Thompson E, et al
    A blood RNA signature for tuberculosis disease risk: a prospective cohort study.
    Lancet. 2016 Mar 23. pii: S0140-6736(15)01316.
    PubMed     Text format     Abstract available
    
    
    
38. HOSSEINIPOUR MC, Bisson GP, Miyahara S, Sun X, et al
    Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
    Lancet. 2016;387:1198-209.
    PubMed     Text format     Abstract available
    
    
    
39. MOHAPATRA PR
    Tuberculosis control.
    Lancet. 2016;387:1160.
    PubMed     Text format    
    
    
    
40. KRANZER K, Khan P, Godfrey-Fausset P, Ayles H, et al
    Tuberculosis control.
    Lancet. 2016;387:1159-60.
    PubMed     Text format    
    
    
    
41. BLACK A, Mwansa-Kambafwile J
    Tuberculosis control.
    Lancet. 2016;387:1159.
    PubMed     Text format    
    
    
    
42. DEL GRANADO M, Lopez R, Victoria J, Volz A, et al
    Tuberculosis control.
    Lancet. 2016;387:1158.
    PubMed     Text format    
    
    
    
43. FUJIWARA PI, Dlodlo RA
    Tuberculosis control.
    Lancet. 2016;387:1158-9.
    PubMed     Text format    
    
    
    
44. GODFREY C, Andersen J, Mngqibisa R, Scott LE, et al
    Tuberculosis control.
    Lancet. 2016;387:1157-8.
    PubMed     Text format    
    
    
    
45. DAS P
    Soumya Swaminathan: re-energising tuberculosis research in India.
    Lancet. 2016;387:1153.
    PubMed     Text format    
    
    
    
46. GHANASHYAM B
    Changing the game for multidrug-resistant tuberculosis.
    Lancet. 2016;387:1149-50.
    PubMed     Text format    
    
    
    
47. GODFREY-FAUSSETT P, Ayles H
    Why are people living with HIV still dying of tuberculosis?
    Lancet. 2016;387:1141-3.
    PubMed     Text format    
    
    
    
48. 
    Unite to end tuberculosis.
    Lancet. 2016;387:1134.
    PubMed     Text format    
    
    
    
49. KERKHOFF AD, Lawn SD
    A breakthrough urine-based diagnostic test for HIV-associated tuberculosis.
    Lancet. 2016 Mar 9. pii: S0140-6736(16)00146.
    PubMed     Text format    
    
    
    
50. PETER JG, Zijenah LS, Chanda D, Clowes P, et al
    Effect on mortality of point-of-care, urine-based lipoarabinomannan testing to guide tuberculosis treatment initiation in HIV-positive hospital inpatients: a pragmatic, parallel-group, multicountry, open-label, randomised controlled trial.
    Lancet. 2016 Mar 9. pii: S0140-6736(15)01092.
    PubMed     Text format     Abstract available
    
    
    February 2016
51. DHEDA K
    Tuberculosis and Poncet's disease: the many faces of an old enemy.
    Lancet. 2016;387:618.
    PubMed     Text format    
    
    
    
52. ARORA S, Prakash TV, Carey RA, Hansdak SG, et al
    Poncet's disease: unusual presentation of a common disease.
    Lancet. 2016;387:617-8.
    PubMed     Text format    
    
    
    January 2016
53. USHER AD
    Global Fund plays hard ball on corruption.
    Lancet. 2016;387:213-4.
    PubMed     Text format    
    
    
    December 2015
54. RITZ N, Brinkmann F, Garcia BS, Tebruegge M, et al
    Tuberculosis in young refugees.
    Lancet. 2015;386:2475-6.
    PubMed     Text format    
    
    
    
55. BURKI T
    Ethiopia could be a model country for tuberculosis control.
    Lancet. 2015;386:2241-2.
    PubMed     Text format    
    
    
    October 2015
56. FURIN J, Akugizibwe P, Ditiu L, Gray G, et al
    No one with HIV should die from tuberculosis.
    Lancet. 2015 Oct 23. pii: S0140-6736(15)00319.
    PubMed     Text format    
    
    
    
57. WATTS G
    Salmaan Keshavjee: tackling tuberculosis (without rocket science).
    Lancet. 2015 Oct 23. pii: S0140-6736(15)00466.
    PubMed     Text format    
    
    
    
58. KESHAVJEE S, Dowdy D, Swaminathan S
    Stopping the body count: a comprehensive approach to move towards zero tuberculosis deaths.
    Lancet. 2015 Oct 23. pii: S0140-6736(15)00320.
    PubMed     Text format    
    
    
    
59. RANGAKA MX, Cavalcante SC, Marais BJ, Thim S, et al
    Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection.
    Lancet. 2015 Oct 23. pii: S0140-6736(15)00323.
    PubMed     Text format     Abstract available
    
    
    
60. ORTBLAD KF, Salomon JA, Barnighausen T, Atun R, et al
    Stopping tuberculosis: a biosocial model for sustainable development.
    Lancet. 2015 Oct 23. pii: S0140-6736(15)00324.
    PubMed     Text format     Abstract available
    
    
    
61. DAS P, Horton R
    Tuberculosis-getting to zero.
    Lancet. 2015 Oct 23. pii: S0140-6736(15)00401.
    PubMed     Text format    
    
    
    
62. THERON G, Jenkins HE, Cobelens F, Abubakar I, et al
    Data for action: collection and use of local data to end tuberculosis.
    Lancet. 2015 Oct 23. pii: S0140-6736(15)00321.
    PubMed     Text format     Abstract available
    
    
    
63. YUEN CM, Amanullah F, Dharmadhikari A, Nardell EA, et al
    Turning off the tap: stopping tuberculosis transmission through active case-finding and prompt effective treatment.
    Lancet. 2015 Oct 23. pii: S0140-6736(15)00322.
    PubMed     Text format     Abstract available
    
    
    September 2015
64. DHEDA K, Barry CE 3rd, Maartens G
    Tuberculosis.
    Lancet. 2015 Sep 11. pii: S0140-6736(15)00151.
    PubMed     Text format     Abstract available
    
    
    
65. SHARMA DC
    Budget cuts threaten AIDS and tuberculosis control in India.
    Lancet. 2015;386:942.
    PubMed     Text format    
    
    
    May 2015
66. SOTGIU G, Migliori GB
    New effective antituberculosis regimens.
    Lancet. 2015;385:1703-4.
    PubMed     Text format    
    
    
    
67. UPLEKAR M, Weil D, Lonnroth K, Jaramillo E, et al
    WHO's new end TB strategy.
    Lancet. 2015;385:1799-801.
    PubMed     Text format    
    
    
    April 2015
68. JIA Z, Ruan Y, Lu Z
    HIV incidence and mortality in China.
    Lancet. 2015;385:1510.
    PubMed     Text format    
    
    

Thank you for your interest in scientific medicine.

AMEDEO Tuberculosis is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: